Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alan Guttmacher Institute (1996) Facts in brief: induced abortion. The Alan Guttmacher Institute, New York
Ashok PW, Penney GC, Flett GM et al. (1998) An effective regimen for early abortion: a report of 2000 consecutive cases. Hum Reprod 13:2962–2965
Beaulieu EE, Segal SJ (eds) (1985) The antiprogesterone steroid RU 486 and human fertility control. Plenum, New York
Beller FK (1996) Wie klein ist zu klein, wie groß ist zu groß? Frauenarzt 37: 929–933
Beller FK, DeProsse CHA (1992) The confusion of trimester and viability and the consequences for the abortion law. J Reprod Med 37: 537–540
Carbonell JLI, Varela L, Velazco A et al. (1999) Early abortion with 800 µg of misopristol by the vaginal route. Contraception 59:219–225
CDC (1980) Abortion surveillance 1978. Centers for Disease Control, Atlanta/GA
Creinin MD, Darney PD (1993) Methotrexate and misoprostol for early abortion. Contraception 48:339–342
Creinin MD, Pymar HC (2001) Mifepristone 100 mg in abortion regimens. Obstet Gynecol 98:434–439
Creinin MD, Vittinghoff E, Keder L et al. (1996) Methotrexate and misoprostol for early abortion: A multicenter trial. I Safety and efficacy. Contraception 53:321–327
Cuttini M, Nadei M, Kaminski M et al. (2000) End-of-life decisions in neonatal care: physicians self-reported practice in seven European countries. Lancet 355:2112–2118
Darney TD, Sweet RL (1989) Routine intraoperative ultrasound for second trimester abortion reduces incidence of uterine perforation. J Ultrasound Med 8:71–75
DGGG (2002) Positionenpapier»Pränataldiagnostik — Beratung und möglicher Schwangerschaftsabbruch«
Elam-Evans DE, Strauss LT, Herndon J et al. (2003) Abortion surveillance — United States, 2000. MMWR CDC Surveill Summ 52(SS-12): 1–32
El-Rafey H, Rasekar D, Abdalla M (1995) Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 332:983–987
Fathalla MF (1997) Gesellschaft und menschliche Reproduktion. Festrede FIGO-Kongress Kopenhagen, Okt. 1997
Grimes DA (1984) Second trimester abortion in the United States. Fam Plann Perspect 16:260–265
Grimes DA, Cook RJ (1992) Mifepristone (RU 486), an abortificiant to prevent abortion. N Engl J Med 327:1088–1089
Grimes DA, Schulz KF, Cates W Jr (1984) Prophylactic antibiotics for curettage. Am J Obstet Gynecol 150:689
Grimes DA, Stubblefield PG (1999) A clinician guide to medical and surgical abortion. Churchill Livingstone, New York, pp 192–216
Grou F, Rodrigues I (1994) The morning-after pill — how long after? Am J Obstet Gynecol 171:1529–1534
Goldberg AB, Greenberg MB, Darney PD (2001) Drug therapy: misopristol and pregnancy. N Engl J Med 334:38–47
Halperin R. Vaknin Z, Langer R et al. (2003) Late midtrimester pregnancy termination in the presence of placenta praevia. J Reprod Med 48: 175–178
Hakim-Elahi E, Tovell HM, Burnhil MS (1990) Complications of first-trimester abortion: a report of 170.000 cases. Obstet Gynecol 76:129–135
Hausknecht RU (1995) Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 333:537–540
Hausknecht R (2003) Mifepristone and misopristol for early medical abortion: 18 months experience in the United States. Contraception 67: 463–465
Henshaw SK, Morrow E (1990) Induced abortion, a world review. Fam Plann Perspect 22:76–120
Hepp H (1996) Pränatalmedizin und reformierter § 218a StGB — oder: die versteckte Indikation. Gynäkologe 29:407–411
Jain JK, Meckstroh M, Park M (2000) A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination. Am J Obstet Gynecol 60:353–356
Johnson TRB, Harris LH, Dalton VK et al. (2005) Language matters: legislation, medical practice, and the classification of abortion procedures. Obstet Gynecol 105:201–204
Lindblom B (1992) Ectopic pregnancy — laparoscopic and medical treatment. Curr Opin Obstet Gynecol 4:400–405
Lippes J, Malik T, Tatum HJ (1976) The post coital copper T. Adv Plann Parenthood 11:24
Mac Isaac L, Creinin MD (2000) Early surgical abortion an alternative and backup for medical abortion. Am J Obstet Gynecol 183:76–83
Mac Isaac L, Grossman B, Baliestreri E, Darney PA (1999) A randomized controlled trial of laminaria, oral misoprostol and vaginal misoprostol before abortion. Obstet Gynecol 93:766–770
McCullogh LB, Chervenak FA (1994) Ethics in obstetrics and gynecology. Oxford University Press
Mund M (2001) Der medikamentöse Schwangerschaftsabbruch mit Mifepriston. Frauenarzt 42:952
Paul M, Lackie E, Mitchell C et al. (2002) Is pathology examination useful after early surgical abortion. Obstet Gynecol 99:567–571
Peyron R, Aubry E, Targosz V, Silvestre L, Renault M, Elkik F et al. (1993) Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 328:1509–1513
Pirruccello EP, Newhall MD, Winikoff R (2000) Abortion with mifepristone and misoprostol: Regimens acceptability and future directions. J Obstet Gynecol 183:44–53
Ross GT, Goldstein M, Hertz R et al. (1965) Sequential use of methotrexate and actinomycin D in the treatment of metastatic chorion carcinoma and related throphoblastic disease in women. Am J Obstet Gynecol 150:189
Schaff EA, Penmeetsa U, Eisinger ST H, Franks P (1997) Methotrexate — a single agent for abortion. J Reprod Med 42:56–60
Schaff EA, Fielding SL, Westhoff C et al. (2000) Vaginal misoprostol administered 1,2 or 3 days after mifeprostone for early medical abortion: a randomized trial. JAMA 284:1984–1953
Schneider D, Bukowsky J, Caspi E (1994) Safety of mid trimester pregnancy termination by laminaria and evacuation in patients with previous cesarean section. Am J Obstet Gynecol 171:554–557
Schneider D, Halparin R, Langer R, Caspi E, Bukowski I (1996) Abortion at 18–22 weeks by laminaria dilatation and evacuation. Obstet Gynecol 88:412–414
Schüssler B (1997) Prostaglandinanwendung in Gynäkologie und Geburtshilfe. Standard-Therapiekonzepte und neue Alternativen. Frauenheilkd Aktuell 1:4–8
Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe, Kommission Qualitätssicherung (2003) Verwendung von Mifepriston für den medikamentösen Schwangerschaftsabbruch. Expertenbrief No 5
Spitz IM, Bardin CW, Benton L et al. (1998) Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 338:1241–1247
Statistisches Bundesamt (2004) Gesundheitswesen, Fachserie 12, Reihe 3
Stoval TG, Ling FW (1993) Single dose methotrexate: an expanded dilatation trail. Am J Obstet Gynecol 48:339–348
Stubblefield PG, Carr-Ellis S, Borgatta L (2004) Methods for induced abortions. Obstet Gynecol 104:174–185
Task Force (1999) Postovulatory Methods for Fertility Regulation: Randomised controll trial of levonogestrel vs the Yupze regimen of combined oral contraception for emergency contraception. Lancet 352:428–433
Todd CS, Soler M, Castleman M et al. (2002) Buccal misoprostol as a cervical preparation for second trimester pregnancy termination. Contraception 65:415–418
Westfall JM, Sophocles A, Burggraf H et al. (1998) Manual vacuum aspiration for trimester abortion. Arch Fam Med 7:559–562
WHO (1991) Pregnancy termination with mifepristone and gemeprost. A multicenter comparison between repeated doses and a single dose of mifepristone. Fertil Steril 56:32–40
Wiebe ER (1999) Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion. Am J Obst Gynecol 181: 149–152
Wiebe ER, Dunns G, Gilbert E et al. (2002) Comparison of abortions induced by methotrexate or Mifepristone followed by Misoprostol. Obstet Gynecol 99:813–819
Winkler M, Rath W (1997) Aktuelles Vorgehen bei der vorzeitigen Schwangerschaftsbeendigung mit Prostaglandinen im II. und III. Trimenon. Z Geburtsh Neonatol 201:39–43
Winkler CL, Gray SE, Hauth JC, Owen J, Tucker JM (1991) Mid second trimester labor induction, concentrated oxytocin compared with Prostaglandin E2 Supp. Obstet Gynecol 77:297–300
Wood SL, Brain PH (2000) Medical management of missed abortion. A randomized clinical trial. Obstet Gynecol 99:563–566
Yupze A, Smith RP, Rademaker AW (1982) A multicenter clinical trial investigation employing ethinylestradiol combined with dl-norgestrel as a postcoital contraceptive agent. Fertil Steril 37:508–513
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Schneider, H., Beller, F.K. (2006). Schwangerschaftsabbruch. In: Schneider, H., Husslein, P., Schneider, KT.M. (eds) Die Geburtshilfe. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33897-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-540-33897-0_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33896-3
Online ISBN: 978-3-540-33897-0
eBook Packages: Medicine (German Language)